CARATOZZOLO, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 1.759
AS - Asia 1.181
EU - Europa 938
SA - Sud America 168
AF - Africa 27
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.076
Nazione #
US - Stati Uniti d'America 1.696
SG - Singapore 487
IT - Italia 347
CN - Cina 285
BR - Brasile 144
DE - Germania 141
FI - Finlandia 117
HK - Hong Kong 109
BD - Bangladesh 90
VN - Vietnam 64
GB - Regno Unito 55
FR - Francia 54
UA - Ucraina 54
RU - Federazione Russa 42
CA - Canada 37
IN - India 36
TR - Turchia 32
NL - Olanda 26
PL - Polonia 26
IE - Irlanda 24
MX - Messico 13
JP - Giappone 11
ZA - Sudafrica 10
AR - Argentina 9
PK - Pakistan 8
SE - Svezia 8
AT - Austria 7
BE - Belgio 7
ES - Italia 7
SA - Arabia Saudita 7
CZ - Repubblica Ceca 6
IQ - Iraq 6
TW - Taiwan 6
IR - Iran 5
VE - Venezuela 5
JO - Giordania 4
LT - Lituania 4
AL - Albania 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GT - Guatemala 3
ID - Indonesia 3
IL - Israele 3
JM - Giamaica 3
KR - Corea 3
MA - Marocco 3
NP - Nepal 3
AU - Australia 2
CI - Costa d'Avorio 2
CL - Cile 2
CO - Colombia 2
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
KZ - Kazakistan 2
NO - Norvegia 2
PE - Perù 2
PY - Paraguay 2
UZ - Uzbekistan 2
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
GE - Georgia 1
GM - Gambi 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.076
Città #
Singapore 298
Ashburn 247
Fairfield 128
San Jose 116
Hong Kong 109
Helsinki 94
New York 72
Woodbridge 65
Milan 64
The Dalles 64
Beijing 61
Houston 59
Los Angeles 55
Seattle 52
Wilmington 50
Munich 47
Brescia 45
Cambridge 45
Jacksonville 44
Ann Arbor 40
Chandler 36
Council Bluffs 30
Lauterbourg 29
Dallas 25
Istanbul 25
Dublin 24
Nanjing 24
Princeton 24
Warsaw 24
Ho Chi Minh City 23
Chicago 20
Turku 20
Buffalo 18
Dearborn 16
Denver 16
São Paulo 16
Montreal 15
Redondo Beach 15
Rome 15
Santa Clara 15
Orem 14
Frankfurt am Main 13
Hanoi 13
San Francisco 13
Des Moines 12
Moscow 12
Mumbai 11
Shanghai 11
Nuremberg 10
Chennai 9
London 9
Jinan 8
Toronto 8
Brussels 7
Guangzhou 7
Naples 7
Stockholm 7
Tokyo 7
Verona 7
Amsterdam 6
Bologna 6
Charlotte 6
Düsseldorf 6
Monza 6
Phoenix 6
Poplar 6
Washington 6
Boardman 5
Boston 5
Brasília 5
Castelli Calepio 5
Changsha 5
Da Nang 5
Elk Grove Village 5
Hangzhou 5
Johannesburg 5
Mexico City 5
Nanchang 5
Ningbo 5
Rio de Janeiro 5
Riyadh 5
Salò 5
San Giuliano Terme 5
Taipei 5
Amman 4
Ardabil 4
Atlanta 4
Bolingbrook 4
Chapel Hill 4
João Pessoa 4
Kunming 4
Norwalk 4
San Diego 4
Turin 4
Venezia 4
Zhengzhou 4
Augusta 3
Baku 3
Belo Horizonte 3
Belém 3
Totale 2.563
Nome #
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 349
COVID-19 impact on consecutive neurological patients admitted to the emergency department 257
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 238
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 222
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 199
Potentially Serious Drug-Drug Interactions in Older Patients Hospitalized for Acute Ischemic and Hemorrhagic Stroke 183
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 183
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 177
Non-amnestic mild cognitive impairment and sleep complaints: a bidirectional relationship? 166
Dementia after Three Months and One Year from Stroke: New Onset or Previous Cognitive Impairment? 140
Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders 125
Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA 114
Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease 109
Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine 104
Rilevazione di segnali disgrafici e grafo-patologici in un gruppo di persone affette da demenza 99
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 99
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine 97
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease 96
Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types 96
Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer’s Disease: A Six-Month, Open-Label, Observational Study 92
An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor 89
Cerebral Amyloid Angiopathy in Alzheimer Disease: A Comparison between Different Versions of the Boston Criteria 89
The impact of COVID-19 on health status of home-dwelling elderly patients with dementia in East Lombardy, Italy: results from COVIDEM network 88
Neurophysiological correlates of altered time awareness in Alzheimer's disease and frontotemporal dementia 85
Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison 80
“Real-world” eligibility for aducanumab depends on clinical setting and patients' journey 80
The role of insulin resistance and APOE genotype on blood–brain barrier integrity in Alzheimer's disease 78
Differences between plasma and CSF p-tau181 and p-tau231 in early Alzheimer’s disease 74
Cerebrospinal fluid cyclase-associated protein 2 is increased in Alzheimer’s disease and correlates with tau pathology 68
Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab 66
Photophobia and migraine outcome during treatment with galcanezumab 60
CGRP-monoclonal antibodies and SARS-CoV-2 vaccination 59
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients 57
Totale 4.118
Categoria #
all - tutte 16.993
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.993


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/2022118 6 21 1 4 1 7 10 10 11 7 12 28
2022/2023146 20 5 8 6 15 33 7 8 22 8 7 7
2023/2024178 15 3 24 9 6 39 4 7 33 4 5 29
2024/2025799 16 5 3 141 65 57 67 51 100 72 126 96
2025/20262.076 155 190 119 235 193 195 346 122 132 170 102 117
Totale 4.118